Wei Xu
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Immunology top 5%
- Genetics top 2%
- Co-authors
- Shimin ZhaoJohn W. ReganYan LinHiromichi FujinoKun‐Liang GuanYue XiongJian‐Yuan ZhaoWei Yu
- Topics
- Inflammatory Bowel Disease (14 papers)Cancer, Hypoxia, and Metabolism (12 papers)Head and Neck Cancer Studies (11 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Wei Xu
159 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Molecular Biology 2.0k
- Cancer Research 1.2k
- Oncology 610
- Immunology 551
- Genetics 546
Countries citing papers authored by Wei Xu
This map shows the geographic impact of Wei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xu more than expected).
Fields of papers citing papers by Wei Xu
This network shows the impact of papers produced by Wei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xu. The network helps show where Wei Xu may publish in the future.
Co-authorship network of co-authors of Wei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xu. A scholar is included among the top collaborators of Wei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xu. Wei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylationbreakdown → | 168 |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 16 | |
| 8 | 4 | |
| 9 | 15 | |
| 10 | 1 | |
| 11 | 20 | |
| 12 | 61 | |
| 13 | 22 | |
| 14 | 32 | |
| 15 | 117 | |
| 16 | 6 | |
| 17 | 43 | |
| 18 | 46 | |
| 19 | Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αbreakdown → | 896 |
| 20 | 72 |
About Wei Xu
Wei Xu is a scholar working on Geriatrics and Gerontology, Otorhinolaryngology and Hematology, having authored 172 papers that have together received 4.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (14 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Head and Neck Cancer Studies (11 papers). The work is most often cited by research in Cancer Research (1.2k citations), Genetics (546 citations) and Geriatrics and Gerontology (182 citations). Wei Xu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Shimin Zhao, John W. Regan, Yan Lin, Hiromichi Fujino, Kun‐Liang Guan, Yue Xiong, Jian‐Yuan Zhao, Wei Yu, Jianping Ding and Zhiqiang Li. Their work appears in journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.